Morphine-induced alterations of immune status are blocked by the dopamine D2-like receptor agonist 7-OH-DPAT.
D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects; D045744:Cell Line, Tumor; D002860:Chromium Radioisotopes / Q000378:metabolism; D003208:Concanavalin A / Q000494:pharmacology; D004298:Dopamine / Q000378:metabolism*; D004305:Dose-Response Relationship, Drug; D004333:Drug Administration Routes; D004347:Drug Interactions; D007107:Immune System / Q000187:drug effects*; D007371:Interferon-gamma / Q000378:metabolism; D007694:Killer Cells, Natural / Q000187:drug effects; D008070:Lipopolysaccharides / Q000494:pharmacology; D008214:Lymphocytes / Q000187:drug effects; D008297:Male; D009020:Morphine / Q000494:pharmacology*; D009294:Narcotics / Q000494:pharmacology; D051381:Rats; D011917:Rats, Inbred Lew; D017448:Receptors, Dopamine D2 / Q000819:agonists*; D013764:Tetrahydronaphthalenes / Q000494:pharmacology*; D013936:Thymidine / Q000378:metabolism; D014316:Tritium / Q000378:metabolism
D002860:Chromium Radioisotopes; D008070:Lipopolysaccharides; D009294:Narcotics; D017448:Receptors, Dopamine D2; D013764:Tetrahydronaphthalenes; D014316:Tritium; D003208:Concanavalin A; D009020:Morphine; D007371:Interferon-gamma; C031349:7-hydroxy-2-N,N-dipropylaminotetralin; D013936:Thymidine; D004298:Dopamine